Emerging Insights into Neurodegeneration: A Proteomic Perspective

Neurodegenerative disorders such as Alzheimer’s, Parkinson’s and multiple sclerosis are on the rise, with cases projected to double in the next 20 years. While many of these conditions are linked to genetic risk factors – such as the APOE4 variant in Alzheimer’s disease – the fact that 40% of APOE4 homozygotes remain unaffected points to the critical role of post-genomic influences, including proteomic and immune system changes.

Fill out the form below to download the white paper

In this white paper, we explore how high-plex proteomics is opening new windows into disease biology. These protein biomarkers are proving critical not only for early detection, but also for tracking disease progression, distinguishing molecular subtypes and informing therapeutic decisions.

Get your free copy
Fill out the form to access the full white paper and explore how cutting-edge proteomics is reshaping our understanding of disease progression, subtypes and treatment response in neurodegenerative diseases.